Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Investor interest in hedge funds surges to pre-financial crisis highs - eVestment

Thursday, March 20, 2014

Bailey McCann, Opalesque New York:

The latest investor asset flow data from eVestment shows that investors are piling into hedge funds like it's 2006. Investors allocated an estimated $41bn in February; the largest monthly allocation since eVestment began tracking monthly flows in October 2008. Total industry AUM of $2.93tn sits only $12bn below its all-time high set in Q2 2008.

Performance gains added an additional $45.9bn, bringing February’s asset increase to $86.9bn, an increase of 3.1%. This is the industry’s largest asset growth since performance gains drove a large increase in May 2009.

In terms of specific strategies, investor preferences for equity over credit persisted for its fourth consecutive month, the longest such streak since investors chased the equity market recovery in the months following the financial crisis. Despite being overshadowed by equity flows, credit strategies showed a significant rebound of investor sentiment in February, more than offsetting the flare of redemptions following the sharp uptick of interest rates in May 2013.

Event driven funds continued to receive large allocations, led by activist strategies that received an estimated $2.1bn in new capital, or roughly 41% of event driven net inflows during the month. Total AUM in funds employing activist strategies reporting to eVestment reached nearly $73bn in February.

Report data shows that investors dipped back into macro strategies in February, with positive flows t......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for